ARCHIVES

SBIR Priority Score Median Must Match R01s Under House Bill

This article is from The Cancer Letter archive.

Vol. 22 No. 26 | June 28, 1996

Download PDF Visit The Full Archive

Related Articles

Children With Recurrent Hodgkin’s Respond To Gemcitabine, Vinorelbine

March 27, 2009

Clinical Trials Approved By NCI CTEP Last Month

January 28, 2011

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

April 29, 1988

DRCCA Board Cool On communications Network, Hears Report On Behavior Program

May 21, 1982

NCI, IARC Sponsors Workshop On EBV

February 14, 1975

In Brief: Wynder To Receive Distinguished Achievement Award From ASPO; Brown Heads council Of Deans

February 24, 1984